Filing Flows › Idexx Laboratories (IDXX) › Capital expenditures
Idexx Laboratories (IDXX) capital expenditures by quarter
Idexx Laboratories' capital expenditures were $28.9M in Q3 2026 (third quarter 2026), +17% from Q2 2026. Over the last 7 quarters it ranged from $24.6M (Q2 2026) to $34.1M (Q2 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $28.9M | +17% | -7% |
| Q2 2026 | $24.6M | -23% | -28% |
| Q1 2026 | $32.0M | +9% | +7% |
| Q4 2025 | $29.4M | -5% | — |
| Q3 2025 | $31.1M | -9% | — |
| Q2 2025 | $34.1M | +14% | — |
| Q1 2025 | $30.0M | — | — |
Q3 2026 at a glance
Idexx Laboratories, Q3 2026: revenue $1.2B (+10% year over year), operating margin 33.1%, net earnings $317M, operating cash flow $450M. The chart follows the revenue to costs, profit and cash.
Questions
What is Idexx Laboratories' capital expenditures?
Idexx Laboratories' capital expenditures were $28.9M in Q3 2026 (third quarter 2026), +17% from Q2 2026.
How has Idexx Laboratories' capital expenditures changed?
Over the last 7 quarters it ranged from $24.6M (Q2 2026) to $34.1M (Q2 2025).